Dr. Alice Shaw Describes LDK378 in ALK-Positive Non-Small Cell Lung Cancer
1 Views
administrator
07/14/23
Alice T. Shaw, MD, PhD, an attending physician in the Center for Thoracic Cancers at Massachusetts General Hospital, discusses the clinical activity of the ALK inhibitor LDK378 in patients with non-small cell lung cancer (NSCLC) harboring an ALK alteration.
This data was presented at the 2013 ASCO Annual Meeting. For more from this meeting, visit http://www.onclive.com/confere....nce-coverage/asco-20
-
Category
Show more
Facebook Comments
No comments found